{
    "Trade/Device Name(s)": [
        "Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Strip",
        "Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Cassette",
        "Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Midstream"
    ],
    "Submitter Information": "Co-Innovation Biotech Co., Ltd.",
    "510(k) Number": "K213808",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132085"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "December 6, 2021",
    "Summary Letter Received Date": "December 6, 2021",
    "Submission Date": "March 31, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Colloidal gold immunoassay"
    ],
    "Methodologies": [
        "Sandwich immunoassay",
        "Qualitative visual detection"
    ],
    "Submission Type(s)": [
        "Strip",
        "Cassette",
        "Midstream"
    ],
    "Document Summary": "FDA 510(k) summary for Co-Innovation One Step HCG Test devices (Strip, Cassette, Midstream) for qualitative visual pregnancy detection in urine using immunochromatographic sandwich assay.",
    "Indications for Use Summary": "In vitro diagnostic visual qualitative immunochromatographic assay for rapid determination of human chorionic gonadotropin (hCG) in urine to aid in the early detection of pregnancy, intended for over-the-counter (OTC) use.",
    "fda_folder": "Clinical Chemistry"
}